| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034664 |
| Receipt No. | R000039520 |
| Scientific Title | Effect on the QOL related to sleep by amino acids intake to healthy adult male and female. |
| Date of disclosure of the study information | 2018/10/26 |
| Last modified on | 2019/05/24 (Ver. 6) |
| Basic information | ||
| Public title | Effect on the QOL related to sleep by amino acids intake to healthy adult male and female. | |
| Acronym | Effect on the QOL related to sleep by amino acids intake. | |
| Scientific Title | Effect on the QOL related to sleep by amino acids intake to healthy adult male and female. | |
| Scientific Title:Acronym | Effect on the QOL related to sleep by amino acids intake. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effect of the QOL related to sleep when compared to placebo for healthy adult male and female workers who consume test food for one week. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | OSA sleep inventory MA version,
Japanese short version of POMS2 |
| Key secondary outcomes | Total time of deep sleep, Total time of sleep, sleep latency, LF/HF ratio, HF |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of food containing amino acids for 1 week | |
| Interventions/Control_2 | Intake of food containing amino acids and L-theanine for 1 week | |
| Interventions/Control_3 | Intake of placebo food for 1 week | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Healthy adult male and female workers from 20 to 64 years of age
(2) The total score of the Zc of OSA sleep inventory MA version is low |
|||
| Key exclusion criteria | (1) Subjects who constantly use health food richly containing involvement ingredient
(2) Subjects who perform an act for the improvement of the quality of the sleep, the stress, and fatigue (3) Subjects whose BMI are 30.0 kg/m^2 or more (4) Subjects who wake up halfway or more due to nighttime urination, child's crying at night, etc. (5) Night and day shift worker or manual laborer (6) During the treatment of diseases affecting sleep or pulse, such as sleep apnea syndrome, chronic fatigue syndrome, autonomic imbalance and the like, a subject having a diagnosis history or a subject to be strongly suspected (7) Subjects of constitution / body that are thought to interfere with wearing of wearable activity meter (8) Subjects who may feel stress due to abstinence or quitting smoking and may affect sleep (9) Subjects who have the potential of developing pollinosis during the study (10) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion (11) Subjects having possibilities for emerging allergy related to the study (12) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (13) Subjects who are judged as unsuitable for the study because of clinical test, anthropometric test and physical examination in pre-inspection (14) Subjects who have participated in other clinical study within the last one month or have plan to participate other clinical studies (15) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study (16) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17) Subjects who are judged as unsuitable for the study by investigator for other reasons |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | EZAKI GLICO Co., Ltd. | ||||||
| Division name | R&D LABORATORY | ||||||
| Zip code | 555-8502 | ||||||
| Address | 4-6-5, UTAJIMA, NISHIYODOGAWA-KU, OSAKA | ||||||
| TEL | 06-6477-8793 | ||||||
| hiroshi.kawabata@glico.com | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | TTC Co., Ltd. | ||||||
| Division name | Clinical Research Planning Department | ||||||
| Zip code | 150-0021 | ||||||
| Address | Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo | ||||||
| TEL | 03-5459-5329 | ||||||
| Homepage URL | |||||||
| s.tsuji@ttc-tokyo.co.jp | |||||||
| Sponsor | |
| Institute | TTC Co., Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | EZAKI GLICO Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Aisei Hospital Ueno Clinic Reserch Ethics Committee |
| Address | 2-18-6, Higashiueno, Taitou-ku, Tokyo |
| Tel | 03-6455-0880 |
| t.saito@ttc-smo.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 60 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039520 |